18850 - Human Photoallergy Test
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: Sunscreening Sport Spray Rest (BAY987519)Other: Untreated skin
- Registration Number
- NCT02751463
- Lead Sponsor
- Bayer
- Brief Summary
To evaluate the potential of a test material to produce a photoallergic response.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
- be male or female between the ages of 18 and 60 inclusive;
- be lightly pigmented (Fitzpatrick Skin Type I, II, III);
- have read and signed the written Informed Consent Form and have completed a Health Insurance Portability and Accountability Act (HIPAA) Authorization Form in conformance with 45CFR Parts 160 and 164;
- be in general good health as determined by the subject's medical history and in the discretion of the investigator.
Exclusion Criteria
- have a visible sunburn;
- have a history of sun hypersensitivity/photosensitivity or photosensitive dermatoses;
- have a known hypersensitivity or allergy against any of the active and non-active ingredients of the investigational products.
- subjects who are employees of the CRO and/or Bayer or is a household member of an employee
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description BAY987519 Sunscreening Sport Spray Rest (BAY987519) All subjects are patched . BAY987519 Untreated skin All subjects are patched .
- Primary Outcome Measures
Name Time Method Intensity of skin reactions is evaluated by 5 point grading scale Up to 72 hours
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie photoallergic reactions to sunscreening agents like BAY987519?
How does BAY987519 compare to standard-of-care sunscreening agents in preventing photoallergic dermatitis?
Are there specific biomarkers that predict individual susceptibility to photoallergy from sport sunscreen sprays?
What are the potential adverse events associated with BAY987519 and how are they managed clinically?
What related compounds or combination therapies are being developed by Bayer for photoallergy prevention in dermatology?